ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Revaprazan hydrochloride
C22H24ClFN4
398.9 g/mol
API

Revaprazan Hydrochloride

CAS178307-42-1
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material

Revaprazan Hydrochloride is a pharmaceutical raw material used as a potassium-competitive acid blocker. It is a salt-like compound with a complex aromatic and heterocyclic structure, developed for research in gastric acid suppression.

pharmaceutical raw materialresearch compound for acid suppression studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 178307-42-1

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Revaprazan

CAS199463-33-7

pharmaceutical raw material

ApplicationSame Use

Fexuprazan

CAS1902954-60-2

pharmaceutical raw material

ApplicationSame Use

Tegoprazan

CAS942195-55-3

pharmaceutical raw material

ApplicationSame Use

TAK 438

CAS1260141-27-2

pharmaceutical raw material

ApplicationSame Use

Vonoprazan Fumarate

CAS2098974-13-9

pharmaceutical raw material

ReferenceSame Category

Prilocaine hydrochloride

CAS1786-81-8

pharmaceutical raw material

ReferenceSame Category

7(S)-Cefdinir

CAS178601-89-3

pharmaceutical raw material

ReferenceSame Category

Agomelatine Impurity 2;

CAS178677-39-9

pharmaceutical raw material

Identifiers
IUPAC Name

N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine;hydrochloride

InChIKey

MALPZYQJEDBIAK-UHFFFAOYSA-N

SMILES

CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F.Cl

Synonyms (17)
  • Revaprazan hydrochloride (USAN)
  • 178307-42-1 (HCl)
  • Revaprazan HCl
  • Revaprazan Hydrochloride
  • SB 641257A